cefoperazone has been researched along with imipenem, anhydrous in 75 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 22 (29.33) | 18.7374 |
| 1990's | 19 (25.33) | 18.2507 |
| 2000's | 19 (25.33) | 29.6817 |
| 2010's | 14 (18.67) | 24.3611 |
| 2020's | 1 (1.33) | 2.80 |
| Authors | Studies |
|---|---|
| Caniça, M; Ferreira, E; Leitão, J; Manageiro, V; Mendonça, N | 1 |
| Ayala, JA; Casellas, JM; Di Conza, J; Ghiglione, B; Gutkind, G; Power, P; Radice, M; Rodríguez, MM | 1 |
| Kwon, DH; Lu, CD | 1 |
| Hsiao, YJ; Hu, RM; Huang, KJ; Wu, LT; Yang, TC | 1 |
| Bonnet, R; Caniça, M; Ferreira, E; Manageiro, V; Mendonça, N; Robin, F; Salgado, MJ | 1 |
| Cai, JC; Chen, GX; Zhang, R; Zhou, HW | 1 |
| Lombardo, F; Obach, RS; Waters, NJ | 1 |
| Arakawa, Y; Ishikawa, K; Nagano, N; Nagano, Y; Wachino, J | 1 |
| Choi, JY; Ko, KS; Lee, MY; Park, YK; Peck, KR; Rhee, JY; Shin, JY; Song, JH | 1 |
| Bai, N; Cai, Y; Li, R; Liang, B; Liu, Y; Wang, R | 1 |
| Collins, B; Cotter, PD; Curtis, N; Hill, C; Ross, RP | 1 |
| Anderson, KC; Kellogg, GE; Sarkar, A | 1 |
| Hopkins, JA; Lami, JL; Wilson, SE | 1 |
| Bruckner, DA; Champlin, RE; Ho, WG; Winston, DJ | 1 |
| Shevchuk, YM | 1 |
| Kobayashi, J; Kouda, M; Kumagai, I; Matsuzaki, H; Sugai, R | 1 |
| Kumagai, K; Nishibuchi, M; Otsuki, H; Takeda, Y | 1 |
| Bruckner, DA; Champlin, RE; Gale, RP; Ho, WG; Winston, DJ | 1 |
| Bodey, GP; Elting, L; Ho, DH | 1 |
| Bale, M; Howard, W; Koontz, F; Pfaller, M; Preston, T | 1 |
| Bulliard, G; Husson, M; Van der Auwera, P | 1 |
| Marks, MI; Parker, KM; Stutman, HR | 1 |
| Black, D; Kirby, WM; Kwok, K; Miller, S; Mortimer, J | 1 |
| Chin, NX; Labthavikul, P; Neu, HC; Saha, G | 1 |
| Jones, RN | 1 |
| Munro, R; Shanker, S; Toohey, M | 1 |
| Gilchrist, MJ; Spelhaug, DR; Washington, JA | 1 |
| Cherubin, CE; Corrado, ML; Landesman, SH | 1 |
| McCloskey, RV; Trent, JA; Tutlane, VA | 1 |
| LeFrock, JL; Miller, MA; Vercler, MJ | 1 |
| Braveny, I; Elsser, R; Machka, K | 1 |
| Neu, HC | 1 |
| Neu, HC; Prince, AS | 1 |
| Ahonkhai, VI; Cherubin, CE; Shulman, MA; Sierra, MF | 1 |
| Meyer, RD; Pasiecznik, K | 1 |
| Chau, PY; Ling, J; Ng, WS | 1 |
| Elliott, TS; Greenwood, D | 1 |
| Le Noc, D; Le Noc, P; Robert, J | 1 |
| Ahonkhai, VI; Bokkenheuser, VD; Cherubin, CE; Mosenthal, AC; Shulman, MA; Sierra, MF | 1 |
| Brown, P; Rand, KH | 1 |
| Budanov, SV; Rezvan, SP; Sidorenko, SV | 1 |
| Matsuo, K; Uete, T | 1 |
| Nakagawa, Y; Toyoguchi, T | 1 |
| Kato, H; Kato, N; Tanaka, Y; Tanaka-Bandoh, K; Ueno, K; Watanabe, K | 1 |
| Abi-Said, D; Bodey, G; Raad, I; Rolston, K; Whimbey, E | 1 |
| Doern, GV; Jones, RN; Pfaller, MA; Salazar, JC | 1 |
| Bartoni, K; Bruckner, DA; Schiller, GJ; Territo, MC; Winston, DJ | 1 |
| Hu, W; Li, J; Zhu, Y | 1 |
| Fukuhara, J; Furuhata, N; Ikeda, A; Kimura, F; Kouda, M; Maruyama, M; Matsuzaki, H; Nomura, H; Ohgawara, M; Ono, E; Sasaki, K; Satoh, H; Sawabe, E; Suzuki, T; Takahashi, I; Takeuchi, M; Tohi, H | 1 |
| Borja, J; Herreras, A | 1 |
| Blondeau, JM; Suter, M; Vaughan, D; Yaschuk, Y | 1 |
| Chan, WC; Cheng, AF; Li, RC; Ling, JM; Schentag, JJ | 1 |
| Başkan, S; Ozyilkan, O; Yalçintaş, U | 1 |
| Chen, M; Xu, Y; Zhang, S | 1 |
| Chen, M; Liu, J; Wang, C; Wang, H; Wang, P; Xie, X; Xu, Y; Yuan, Y; Zhang, X; Zhang, Y | 1 |
| Karasawa, T; Kuriyama, T; Nakagawa, K; Nakamura, S; Yamamoto, E | 1 |
| Chen, P; Cheng, WC; Xiang, XD; Zan, JN | 1 |
| Beketov, AS; Komarov, RM; Pisarev, VV; Sidorenko, SV | 1 |
| Li, L; Ma, Y; Yu, Y; Zhou, Z | 1 |
| Lee, WS; Lin, ML; Liu, CY; Wang, FD | 1 |
| Cao, WF; Peng, YZ; Wang, HM; Xiao, GX; Yang, XY | 1 |
| Jiang, JH; Su, DH; Xiao, QZ; Zhong, NS | 1 |
| Choi, JY; Kim, CO; Kim, JM; Kim, MS; Kim, YA; Kim, YK; Lee, K; Park, YS; Shin, SY; Song, YG; Yong, D; Yoon, HJ | 1 |
| Alp, E; Aygen, B; Metan, G; Sumerkan, B | 1 |
| Tuğrul, HM; Yıldırım, MI | 1 |
| Chen, Y; Du, X; Fu, Y; Ji, J; Wang, H; Yu, Y | 1 |
| Bao, Y; Cai, Y; Chai, T; Gao, J; Li, X; Ma, R; Zhao, X; Zhou, Y | 1 |
| Arslan, U; Kus, H; Tuncer, I; Turk Dagi, H | 1 |
| Araya, I; Contreras, S; Fasce, G; Hurtado, V; Núñez, E; Opazo, JL; Quiñones, LA; Saez, E | 1 |
| Ji, JS; Quan, JJ; Wang, HP; Wang, Y; Wang, YF; Xu, YC; Yu, YS | 1 |
| Gao, L; Li, Y; Lyu, Y | 1 |
| Ali, I; Shabbir, M | 1 |
| Hao, D; Hu, Z; Liu, X; Sun, T; Tian, H; Wang, T; Wang, X | 1 |
| Ejaz, A; Ejaz, H; Javed, H; Saleem, R; Younas, S; Zafar, A | 1 |
| Dang, ZL; Li, B; Qin, HY; Rao, Z; Wei, YH; Wu, XA; Zhu, L | 1 |
2 review(s) available for cefoperazone and imipenem, anhydrous
| Article | Year |
|---|---|
Gram-positive superinfections following beta-lactam chemotherapy: the significance of the enterococcus.
Topics: Anti-Bacterial Agents; Bacterial Infections; Cefoperazone; Cefotaxime; Ceftazidime; Gram-Positive Bacteria; Humans; Imipenem; Moxalactam; Penicillin Resistance; Penicillins; Streptococcus; Thienamycins | 1985 |
The in vitro activity, human pharmacology, and clinical effectiveness of new beta-lactam antibiotics.
Topics: Anti-Bacterial Agents; beta-Lactams; Cefmenoxime; Cefmetazole; Cefoperazone; Cefotaxime; Cefotiam; Cefsulodin; Ceftazidime; Ceftizoxime; Ceftriaxone; Cephalosporins; Cephamycins; Drug Interactions; Drug Resistance, Microbial; Enterobacteriaceae; Enterobacteriaceae Infections; Humans; Imipenem; Moxalactam | 1982 |
10 trial(s) available for cefoperazone and imipenem, anhydrous
| Article | Year |
|---|---|
Adjunctive antimicrobials in surgery of soft tissue infections: evaluation of cephalosporins and carbapenems.
Topics: Adult; Aged; Bacterial Infections; Carbapenems; Cefmetazole; Cefoperazone; Cefotetan; Cefoxitin; Cephalosporins; Drug Combinations; Drug Resistance, Microbial; Escherichia coli Infections; Female; Humans; Imipenem; Male; Meropenem; Middle Aged; Prospective Studies; Remission Induction; Skin Diseases, Infectious; Staphylococcal Infections; Streptococcal Infections; Thienamycins | 1991 |
Beta-lactam antibiotic therapy in febrile granulocytopenic patients. A randomized trial comparing cefoperazone plus piperacillin, ceftazidime plus piperacillin, and imipenem alone.
Topics: Adolescent; Adult; Aged; Agranulocytosis; Anti-Bacterial Agents; Bacterial Infections; Cefoperazone; Ceftazidime; Costs and Cost Analysis; Drug Therapy, Combination; Female; Fever; Gram-Negative Bacterial Infections; Gram-Positive Bacterial Infections; Humans; Imipenem; Male; Microbial Sensitivity Tests; Middle Aged; Piperacillin; Superinfection | 1991 |
Controlled trials of double beta-lactam therapy with cefoperazone plus piperacillin in febrile granulocytopenic patients.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Agranulocytosis; Bacterial Infections; Cefoperazone; Ceftazidime; Clinical Trials as Topic; Drug Therapy, Combination; Female; Fever; Humans; Imipenem; Male; Middle Aged; Moxalactam; Neoplasms; Piperacillin; Random Allocation; Thienamycins | 1988 |
Comparison of cefoperazone and mezlocillin with imipenem as empiric therapy in febrile neutropenic cancer patients.
Topics: Adult; Agranulocytosis; Anti-Bacterial Agents; Bacterial Infections; Cefoperazone; Cilastatin; Cilastatin, Imipenem Drug Combination; Cyclopropanes; Drug Combinations; Drug Therapy, Combination; Female; Fever; Humans; Imipenem; Male; Mezlocillin; Neoplasms; Neutropenia; Thienamycins | 1988 |
Imipenem or cefoperazone-sulbactam combined with vancomycin for therapy of presumed or proven infection in neutropenic cancer patients.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Cefoperazone; Drug Therapy, Combination; Humans; Imipenem; Middle Aged; Neoplasms; Neutropenia; Prospective Studies; Sulbactam; Vancomycin | 1996 |
Randomized comparison of sulbactam/cefoperazone with imipenem as empirical monotherapy for febrile granulocytopenic patients.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Agranulocytosis; Cefoperazone; Drug Therapy, Combination; Female; Fever; Humans; Imipenem; Male; Microbial Sensitivity Tests; Middle Aged; Prospective Studies; Sulbactam; Superinfection | 1998 |
[A randomized clinical study of sulperazone versus tienam in the treatment of LRTIS].
Topics: Adolescent; Adult; Aged; Anti-Bacterial Agents; Bronchitis; Cefoperazone; Drug Combinations; Female; Humans; Imipenem; Male; Middle Aged; Pneumonia; Sulbactam; Thienamycins | 1996 |
Imipenem-cilastatin versus sulbactam-cefoperazone plus amikacin in the initial treatment of febrile neutropenic cancer patients.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amikacin; Bacteremia; Cefoperazone; Cilastatin; Drug Therapy, Combination; Female; Fever; Humans; Imipenem; Male; Middle Aged; Neoplasms; Neutropenia; Prospective Studies; Sulbactam | 1999 |
[Comparative clinical and epidemiological evaluation of beta-lactam antibiotics in the treatment of intraabdominal infections].
Topics: Abdomen; Anti-Bacterial Agents; Bacterial Infections; Cefepime; Cefoperazone; Cephalosporins; Clinical Trials as Topic; Costs and Cost Analysis; Drug Combinations; Humans; Imipenem; Meropenem; Models, Economic; Sulbactam; Thienamycins | 2003 |
[Changes in plasma levels of LPS, TNFalpha and IL-6 in burn patients with severe infection treated with Imipenem or Cefoperazone].
Topics: Burns; Cefoperazone; Female; Gram-Negative Bacterial Infections; Humans; Imipenem; Interleukin-6; Lipopolysaccharides; Male; Tumor Necrosis Factor-alpha | 2004 |
63 other study(ies) available for cefoperazone and imipenem, anhydrous
| Article | Year |
|---|---|
Spread of extended-spectrum beta-lactamase CTX-M-producing escherichia coli clinical isolates in community and nosocomial environments in Portugal.
Topics: Aged; Anti-Bacterial Agents; beta-Lactamases; Community-Acquired Infections; Cross Infection; Drug Resistance, Bacterial; Escherichia coli; Escherichia coli Infections; Escherichia coli Proteins; Humans; Microbial Sensitivity Tests; Middle Aged; Portugal | 2007 |
Biochemical characterization of PER-2 and genetic environment of blaPER-2.
Topics: Amino Acid Sequence; Base Sequence; beta-Lactam Resistance; beta-Lactamases; Catalysis; Citrobacter freundii; Conjugation, Genetic; DNA, Bacterial; DNA, Recombinant; Enterobacteriaceae; Genes, Bacterial; Humans; Hydrolysis; Isoelectric Focusing; Kinetics; Mass Spectrometry; Microbial Sensitivity Tests; Molecular Sequence Data; Molecular Weight; Plasmids; Polymerase Chain Reaction; Promoter Regions, Genetic; Protein Conformation; Protein Sorting Signals; Sequence Analysis, DNA | 2007 |
Polyamine effects on antibiotic susceptibility in bacteria.
Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactams; Drug Resistance, Bacterial; Drug Synergism; Gram-Negative Bacteria; Humans; Microbial Sensitivity Tests; Polyamines; Spermine; Staphylococcus aureus | 2007 |
Induction of L1 and L2 beta-lactamases of Stenotrophomonas maltophilia.
Topics: Anti-Bacterial Agents; beta-Lactamases; beta-Lactams; Catechol 2,3-Dioxygenase; Enzyme Induction; Gene Expression Regulation, Bacterial; Humans; Microbial Sensitivity Tests; Molecular Sequence Data; Mutation; Sequence Analysis, DNA; Stenotrophomonas maltophilia | 2008 |
The Lys234Arg substitution in the enzyme SHV-72 is a determinant for resistance to clavulanic acid inhibition.
Topics: Amino Acid Substitution; Amoxicillin; Anti-Bacterial Agents; Arginine; Aztreonam; Bacterial Proteins; beta-Lactamase Inhibitors; beta-Lactamases; Cephalosporins; Clavulanic Acid; Computer Simulation; Imipenem; Isoelectric Focusing; Kinetics; Klebsiella pneumoniae; Lysine; Microbial Sensitivity Tests; Models, Molecular; Molecular Sequence Data; Penicillins; Protein Conformation; Protein Structure, Tertiary | 2008 |
Emergence of Serratia marcescens, Klebsiella pneumoniae, and Escherichia coli Isolates possessing the plasmid-mediated carbapenem-hydrolyzing beta-lactamase KPC-2 in intensive care units of a Chinese hospital.
Topics: Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactamases; beta-Lactams; Carbapenems; China; Conjugation, Genetic; Electrophoresis, Gel, Pulsed-Field; Escherichia coli; Hospitals, University; Humans; Hydrolysis; Intensive Care Units; Klebsiella pneumoniae; Microbial Sensitivity Tests; Plasmids; Polymerase Chain Reaction; Serratia marcescens | 2008 |
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Novel chimeric beta-lactamase CTX-M-64, a hybrid of CTX-M-15-like and CTX-M-14 beta-lactamases, found in a Shigella sonnei strain resistant to various oxyimino-cephalosporins, including ceftazidime.
Topics: Amino Acid Sequence; beta-Lactamases; Blotting, Southern; Ceftazidime; Cephalosporins; Kinetics; Microbial Sensitivity Tests; Molecular Sequence Data; Polymerase Chain Reaction; Sequence Homology, Amino Acid; Shigella sonnei | 2009 |
KPC-producing extreme drug-resistant Klebsiella pneumoniae isolate from a patient with diabetes mellitus and chronic renal failure on hemodialysis in South Korea.
Topics: Aged; beta-Lactamases; Diabetic Nephropathies; Humans; Kidney Failure, Chronic; Klebsiella Infections; Klebsiella pneumoniae; Male; Renal Dialysis; Republic of Korea | 2010 |
In vitro antimicrobial activity and mutant prevention concentration of colistin against Acinetobacter baumannii.
Topics: Acinetobacter baumannii; Anti-Bacterial Agents; Colistin; Drug Resistance, Multiple, Bacterial; Microbial Sensitivity Tests; Mutation | 2010 |
The ABC transporter AnrAB contributes to the innate resistance of Listeria monocytogenes to nisin, bacitracin, and various beta-lactam antibiotics.
Topics: Anti-Bacterial Agents; ATP-Binding Cassette Transporters; Bacitracin; Bacterial Proteins; beta-Lactam Resistance; Listeria monocytogenes; Nisin | 2010 |
Computational analysis of structure-based interactions and ligand properties can predict efflux effects on antibiotics.
Topics: Anti-Bacterial Agents; beta-Lactams; Computational Biology; Drug Resistance, Bacterial; Hydrophobic and Hydrophilic Interactions; Ligands; Membrane Transport Proteins; Microbial Sensitivity Tests; Models, Molecular; Protein Binding; Protein Conformation; Quantitative Structure-Activity Relationship; Regression Analysis; Thermodynamics | 2012 |
Antimicrobial agents in neutropenic patients with unexplained fever.
Topics: Anti-Bacterial Agents; Cefoperazone; Ceftazidime; Cilastatin; Cilastatin, Imipenem Drug Combination; Drug Combinations; Fever of Unknown Origin; Humans; Imipenem; Infections; Neutropenia | 1991 |
[Combined effect of sulbactam/cefoperazone and other antibiotics against clinical isolates of multi-resistant strains. II. In vitro combined effects of sulbactam/cefoperazone with imipenem/cilastatin, cefuzonam, flomoxef, amikacin or tobramycin].
Topics: Amikacin; Anti-Bacterial Agents; Bacteria; Cefoperazone; Ceftizoxime; Cephalosporins; Cilastatin; Drug Resistance, Microbial; Drug Synergism; Drug Therapy, Combination; Humans; Imipenem; Sulbactam; Tobramycin | 1991 |
[An in vitro study on combination effect of isepamicin and beta-lactam antibiotics].
Topics: Anti-Bacterial Agents; Cefoperazone; Cilastatin; Cilastatin, Imipenem Drug Combination; Drug Combinations; Drug Synergism; Drug Therapy, Combination; Gentamicins; Imipenem; Klebsiella pneumoniae; Microbial Sensitivity Tests; Moxalactam; Pseudomonas aeruginosa; Serratia marcescens | 1990 |
Survey of antibiotic susceptibility among gram-negative bacilli at a cancer hospital.
Topics: Anti-Bacterial Agents; Aztreonam; Cefoperazone; Ceftazidime; Ciprofloxacin; Gram-Negative Bacteria; Humans; Imipenem; Microbial Sensitivity Tests; Neoplasms; Piperacillin; Thienamycins | 1988 |
In vitro inhibitory and bactericidal activity of cefpiramide and seven antipseudomonal agents against Pseudomonas aeruginosa.
Topics: Amikacin; Aminoglycosides; Anti-Bacterial Agents; Azlocillin; Cefoperazone; Cefsulodin; Ceftazidime; Cephalosporins; Drug Combinations; Drug Synergism; Gentamicins; Humans; Imipenem; Microbial Sensitivity Tests; Piperacillin; Pseudomonas aeruginosa; Thienamycins; Time Factors; Tobramycin | 1986 |
Study of in vitro selected resistance of Pseudomonas aeruginosa to cefoperazone, ceftazidime, azthreonam and imipenem.
Topics: Amikacin; Anti-Bacterial Agents; Aztreonam; beta-Lactamases; Cefoperazone; Ceftazidime; Drug Resistance, Microbial; Imipenem; Phenotype; Pseudomonas aeruginosa; Thienamycins | 1986 |
Potential of moxalactam and other new antimicrobial agents for bilirubin-albumin displacement in neonates.
Topics: Anti-Bacterial Agents; Azlocillin; Aztreonam; Bilirubin; Binding Sites; Cefoperazone; Ciprofloxacin; Enoxacin; Humans; Imipenem; In Vitro Techniques; Infant, Newborn; Moxalactam; Naphthyridines; Quinolines; Serum Albumin; Thienamycins | 1985 |
In vitro activity against aerobic and anaerobic gram-positive and gram-negative bacteria and beta-lactamase stability of RS-533, a novel carbapenem.
Topics: Aztreonam; beta-Lactamase Inhibitors; beta-Lactamases; Cefoperazone; Cefotaxime; Cefoxitin; Ceftazidime; Gram-Negative Bacteria; Gram-Positive Bacteria; Imipenem; Microbial Sensitivity Tests; Piperacillin; Thienamycins; Tobramycin | 1986 |
In vitro activity of seventeen antimicrobial agents against Gardnerella vaginalis.
Topics: 4-Quinolones; Anti-Bacterial Agents; Anti-Infective Agents; Cefoperazone; Cephalosporins; Clindamycin; Drug Resistance, Microbial; Erythromycin; Gardnerella vaginalis; Haemophilus; Imipenem; Microbial Sensitivity Tests; Nitroimidazoles; Quinolines; Quinolones; Thienamycins | 1982 |
Bactericidal activity of antibiotics against Campylobacter fetus subspecies intestinalis.
Topics: Ampicillin; Campylobacter; Campylobacter fetus; Cefoperazone; Cefotaxime; Cephalosporins; Cephalothin; Cephamycins; Gentamicins; Imipenem; Lactams; Microbial Sensitivity Tests; Moxalactam; Streptomycin | 1981 |
Influence of inoculum size on activity of cefoperazone, cefotaxime, moxalactam, piperacillin, and N-formimidoyl thienamycin (MK0787) against Pseudomonas aeruginosa.
Topics: Anti-Bacterial Agents; Cefoperazone; Cefotaxime; Cephalosporins; Cephamycins; Imipenem; Lactams; Microbial Sensitivity Tests; Moxalactam; Penicillins; Piperacillin; Pseudomonas aeruginosa | 1980 |
In vitro comparison of N-formimidoyl thienamycin, piperacillin, cefotaxime, and cefoperazone.
Topics: Aerobiosis; Anti-Bacterial Agents; Bacteria; Bacterial Infections; Cefoperazone; Cefotaxime; Cephalosporins; Humans; Imipenem; Lactams; Penicillins; Piperacillin; Species Specificity | 1981 |
Comparative activity of N-formimidoyl thienamycin with third generation cephalosporins and ureido penicillins against multiple resistant Serratia marcescens.
Topics: Azlocillin; Cefoperazone; Cefotaxime; Cephalosporins; Cephamycins; Humans; Imipenem; Lactams; Mezlocillin; Microbial Sensitivity Tests; Moxalactam; Penicillin Resistance; Penicillins; Piperacillin; Serratia marcescens | 1981 |
Antibacterial activity of N-formimidoyl thienamycin in comparison with cefotaxime, lamoxactam, cefoperazone, piperacillin gentamicin.
Topics: Anti-Bacterial Agents; Bacteria; Cefoperazone; Cefotaxime; Cephalosporins; Cephamycins; Gentamicins; Imipenem; Lactams; Microbial Sensitivity Tests; Moxalactam; Penicillins; Piperacillin | 1982 |
Activities of new beta-lactam antibiotics against isolates of Pseudomonas aeruginosa from patients with cystic fibrosis.
Topics: Anti-Bacterial Agents; beta-Lactams; Carbenicillin; Cefoperazone; Cefotaxime; Ceftazidime; Cephalosporins; Cystic Fibrosis; Imipenem; Penicillins; Piperacillin; Pseudomonas aeruginosa; Pseudomonas Infections | 1981 |
The comparative activities of N-formimidoyl theinamycin (MK0787), moxalactam, cefotaxime and cefoperazone against Yersinia enterocolitica and Listeria monocytogenes.
Topics: Anti-Bacterial Agents; Cefoperazone; Cefotaxime; Cephalosporins; Cephamycins; Imipenem; Lactams; Listeria monocytogenes; Moxalactam; Yersinia | 1982 |
In vitro activity of newer beta-lactam agents in combination with amikacin against Pseudomonas aeruginosa, Klebsiella pneumoniae, and Serratia marcescens.
Topics: Amikacin; Anti-Bacterial Agents; Cefoperazone; Cefotaxime; Ceftazidime; Ceftizoxime; Cephalosporins; Drug Synergism; Imipenem; Kanamycin; Klebsiella pneumoniae; Microbial Sensitivity Tests; Moxalactam; Pseudomonas aeruginosa; Serratia marcescens; Thienamycins | 1983 |
Cefoperazone against carbenicillin-resistant isolates of Pseudomonas aeruginosa: comparison with other newer cephalosporins and N-formimidoyl thienamycin.
Topics: beta-Lactamases; Carbenicillin; Cefoperazone; Cephalosporins; Conjugation, Genetic; Imipenem; Microbial Sensitivity Tests; Penicillin Resistance; Pseudomonas aeruginosa; Thienamycins | 1983 |
The morphological response of Pseudomonas aeruginosa to azthreonam, cefoperazone, ceftazidime and N-formimidoyl thienamycin.
Topics: Anti-Bacterial Agents; Aztreonam; Cefoperazone; Ceftazidime; Cephalosporins; Imipenem; Microbial Sensitivity Tests; Microscopy, Electron; Nephelometry and Turbidimetry; Pseudomonas aeruginosa; Spheroplasts; Thienamycins | 1984 |
[Comparative in vitro activity of 5 beta-lactams (cefoperazone, cefsulodin, ceftazidime, azthreonam, N-formimidoyl-thienamycin) on 90 strains of Pseudomonas aeruginosa with various levels of resistance to ticarcillin].
Topics: Anti-Bacterial Agents; Aztreonam; Cefoperazone; Cefsulodin; Ceftazidime; Cephalosporins; Imipenem; Penicillin Resistance; Penicillins; Pseudomonas aeruginosa; Thienamycins; Ticarcillin | 1984 |
In vitro susceptibility of Campylobacter fetus subsp. jejuni to N-formimidoyl thienamycin, rosaramicin, cefoperazone, and other antimicrobial agents.
Topics: Animals; Anti-Bacterial Agents; Campylobacter; Campylobacter fetus; Campylobacter Infections; Cefoperazone; Cephalosporins; Chickens; Humans; Imipenem; Lactams; Leucomycins; Microbial Sensitivity Tests | 1981 |
Concentration-dependent synergy and antagonism between cefoperazone and imipenem against methicillin-resistant Staphylococcus aureus.
Topics: Cefoperazone; Colony Count, Microbial; Drug Synergism; Imipenem; Methicillin Resistance; Staphylococcus aureus | 1995 |
[Comparative in vitro activity of ampicillin, cefoperazone and their combinations with sulbactam, as well as that of other antibiotics against anaerobic organisms].
Topics: Ampicillin; Bacteria, Anaerobic; Cefoperazone; Cefoxitin; Drug Combinations; Drug Resistance, Microbial; Imipenem; Metronidazole; Microbial Sensitivity Tests; Sulbactam | 1995 |
Synergistic enhancement of in vitro antimicrobial activity of imipenem and cefazolin, cephalothin, cefotiam, cefamandole or cefoperazone in combination against methicillin-sensitive and -resistant Staphylococcus aureus.
Topics: Cefamandole; Cefazolin; Cefoperazone; Cefotiam; Cephalothin; Drug Resistance, Microbial; Drug Synergism; Imipenem; Methicillin Resistance; Staphylococcus aureus | 1995 |
[Nephrotoxicity and drug interaction of vancomycin (2)].
Topics: Animals; Blood Urea Nitrogen; Cefoperazone; Ceftazidime; Cephalosporins; Cilastatin; Cilastatin, Imipenem Drug Combination; Creatinine; Drug Combinations; Drug Interactions; Drug Therapy, Combination; Fosfomycin; Imipenem; Kidney; Male; Organ Size; Rabbits; Vancomycin | 1996 |
[In vitro activities of sulopenem, a new parenteral penem, against anaerobes].
Topics: Ampicillin; Animals; Anti-Bacterial Agents; Bacteria, Anaerobic; beta-Lactamases; beta-Lactams; Cecum; Cefoperazone; Ceftizoxime; Cephalosporins; Clostridioides difficile; Drug Stability; Drug Therapy, Combination; Imipenem; Lactams; Male; Mice; Mice, Inbred ICR; Sulbactam; Thienamycins | 1996 |
Multicenter evaluation of antimicrobial resistance to six broad-spectrum beta-lactams in Colombia using the Etest method. The Colombian Antimicrobial Resistance Study Group.
Topics: Anti-Bacterial Agents; Aztreonam; beta-Lactam Resistance; Cefepime; Cefoperazone; Cefotaxime; Ceftazidime; Cephalosporinase; Cephalosporins; Cohort Studies; Colombia; Enterobacteriaceae; Gram-Negative Bacteria; Humans; Imipenem; Microbial Sensitivity Tests; Reproducibility of Results; Staphylococcus; Sulbactam | 1997 |
[Evaluation of antibacterial activities of various antibiotics against glucose non-fermentative gram-negative rods other than Pseudomonas aeruginosa].
Topics: Anti-Bacterial Agents; Cefoperazone; Cephalosporins; Drug Resistance, Microbial; Drug Therapy, Combination; Gentamicins; Gram-Negative Aerobic Rods and Cocci; Humans; Imipenem; Minocycline; Penicillin Resistance; Penicillins; Piperacillin; Sulbactam; Thienamycins | 1998 |
Comparison of sulbactam/cefoperazone with imipenem as empirical monotherapy for febrile granulocytopenic patients.
Topics: Agranulocytosis; Anti-Bacterial Agents; Cefoperazone; Cephalosporins; Fever; Humans; Imipenem; Sulbactam; Thienamycins | 1999 |
In-vitro susceptibility of 1982 respiratory tract pathogens and 1921 urinary tract pathogens against 19 antimicrobial agents: a Canadian multicentre study. Canadian Antimicrobial Study Group.
Topics: Acinetobacter; Anti-Bacterial Agents; Cefoperazone; Ceftazidime; Ciprofloxacin; Clavulanic Acids; Enterobacteriaceae; Enterobacteriaceae Infections; Enterococcus; Haemophilus; Humans; Imipenem; Inhibitory Concentration 50; Microbial Sensitivity Tests; Moraxella; Pseudomonas; Respiratory Tract Infections; Staphylococcus; Streptococcus; Ticarcillin; Urinary Tract Infections | 1999 |
Markedly different rates and resistance profiles exhibited by seven commonly used and newer beta-lactams on the selection of resistant variants of Enterobacter cloacae.
Topics: Anti-Bacterial Agents; beta-Lactam Resistance; Cefamandole; Cefepime; Cefoperazone; Ceftazidime; Ceftriaxone; Cephalosporins; Drug Resistance, Microbial; Enterobacter cloacae; Imipenem; Meropenem; Microbial Sensitivity Tests; Thienamycins | 1999 |
[Multicenter evaluation of the antimicrobial activity in vitro for six broad-spectrum beta-lactams in China using the E-test method].
Topics: Anti-Bacterial Agents; Bacteria; beta-Lactams; Cefepime; Cefoperazone; Ceftazidime; Ceftriaxone; Cephalosporins; China; Imipenem; Microbial Sensitivity Tests; Piperacillin | 2000 |
In vitro activity of meropenem and four other antibiotics against 554 clinical strains obtained from Beijing in 1999.
Topics: Anti-Bacterial Agents; Cefepime; Cefoperazone; Ceftazidime; Cephalosporins; Enterobacteriaceae; Humans; Imipenem; Meropenem; Thienamycins | 2000 |
Antimicrobial susceptibility of major pathogens of orofacial odontogenic infections to 11 beta-lactam antibiotics.
Topics: Anti-Bacterial Agents; Bacteria; Bacterial Infections; Bacteroidaceae Infections; beta-Lactams; Cefepime; Cefmetazole; Cefoperazone; Cefpirome; Ceftazidime; Ceftizoxime; Cephalosporins; Drug Resistance, Bacterial; Drug Therapy, Combination; Fusobacterium; Fusobacterium Infections; Gram-Positive Bacterial Infections; Humans; Imipenem; Lactams; Microbial Sensitivity Tests; Mouth Diseases; Penicillin G; Penicillins; Peptostreptococcus; Porphyromonas gingivalis; Prevotella; Streptococcal Infections; Streptococcus; Sulbactam | 2002 |
[Distribution of bacteria and analysis of their sensibility to antibiotics in patients with hospital-acquired pneumonia].
Topics: Adult; Aged; Aged, 80 and over; Cefoperazone; Ceftriaxone; Cross Infection; Female; Humans; Imipenem; Klebsiella Infections; Klebsiella pneumoniae; Male; Middle Aged; Pneumonia, Bacterial; Pseudomonas aeruginosa; Pseudomonas Infections; Staphylococcal Infections; Staphylococcus epidermidis | 2000 |
The status of drug resistance and ampC gene expression in Enterobacter cloacae.
Topics: beta-Lactamases; Cefoperazone; Drug Resistance, Bacterial; Enterobacter cloacae; Gene Expression; Genes, Bacterial; Imipenem; Microbial Sensitivity Tests; Polymerase Chain Reaction; Sulbactam | 2003 |
In vitro activities of beta-lactam antibiotics alone and in combination with sulbactam against Gram-negative bacteria.
Topics: Acinetobacter baumannii; Ampicillin; Anti-Bacterial Agents; Aztreonam; beta-Lactams; Cefepime; Cefoperazone; Cefotaxime; Ceftazidime; Cephalosporins; Drug Combinations; Drug Resistance, Bacterial; Enterobacter cloacae; Enzyme Inhibitors; Gram-Negative Bacteria; Humans; Imipenem; Klebsiella pneumoniae; Microbial Sensitivity Tests; Serratia marcescens; Sulbactam | 2004 |
[Distribution and drug-resistance of 3 500 gram-negative bacteria in Guangzhou].
Topics: Ampicillin Resistance; Cefoperazone; China; Drug Resistance, Bacterial; Escherichia coli; Gram-Negative Bacteria; Humans; Imipenem; Klebsiella pneumoniae; Microbial Sensitivity Tests; Pseudomonas aeruginosa | 2005 |
Comparison of efficacy of cefoperazone/sulbactam and imipenem/cilastatin for treatment of Acinetobacter bacteremia.
Topics: Acinetobacter; Acinetobacter Infections; Adolescent; Adult; Aged; Anti-Bacterial Agents; Bacteremia; Cefoperazone; Cilastatin; Drug Resistance, Bacterial; Drug Therapy, Combination; Female; Humans; Imipenem; Male; Middle Aged; Protease Inhibitors; Sulbactam | 2006 |
Carbapenem-resistant Acinetobacter baumannii: an emerging threat for patients with post-neurosurgical meningitis.
Topics: Acinetobacter baumannii; Adolescent; Adult; Aged; Amikacin; Anti-Bacterial Agents; Carbapenems; Cefepime; Cefoperazone; Cephalosporins; Ciprofloxacin; Drug Resistance, Bacterial; Female; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; Imipenem; Male; Meningitis, Bacterial; Meropenem; Microbial Sensitivity Tests; Middle Aged; Neurosurgical Procedures; Postoperative Complications; Thienamycins; Turkey | 2007 |
[Assessment of efficacies of imipenem, cefoperazone-sulbactam and cefepime in rats with experimental thigh abscess model with multidrug resistant and susceptible Acinetobacter baumannii strains].
Topics: Abscess; Acinetobacter baumannii; Acinetobacter Infections; Animals; Anti-Bacterial Agents; Cefepime; Cefoperazone; Cephalosporins; Colony Count, Microbial; Disease Models, Animal; Drug Combinations; Drug Resistance, Multiple, Bacterial; Female; Imipenem; Random Allocation; Rats; Rats, Wistar; Serum Bactericidal Test; Soft Tissue Infections; Sulbactam; Thigh | 2011 |
In vitro activity of sulbactam in combination with imipenem, meropenem, panipenem or cefoperazone against clinical isolates of Acinetobacter baumannii.
Topics: Acinetobacter baumannii; Acinetobacter Infections; beta-Lactams; Cefoperazone; Drug Resistance, Bacterial; Drug Therapy, Combination; Humans; Imipenem; Meropenem; Microbial Sensitivity Tests; Sulbactam; Thienamycins | 2013 |
Antibiotic resistance and OXA-type carbapenemases-encoding genes in airborne Acinetobacter baumannii isolated from burn wards.
Topics: Acinetobacter baumannii; Air Microbiology; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Burn Units; Carbapenems; Cefoperazone; Ceftriaxone; Ciprofloxacin; DNA, Bacterial; Drug Resistance, Multiple, Bacterial; Humans; Imipenem; Microbial Sensitivity Tests; Polymerase Chain Reaction; Repetitive Sequences, Nucleic Acid; Sulbactam | 2014 |
[In vitro synergistic activity of sulbactam in combination with imipenem, meropenem and cefoperazone against carbapenem-resistant Acinetobacter baumannii isolates].
Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; beta-Lactam Resistance; Carbapenems; Cefoperazone; Cross Infection; Drug Combinations; Drug Synergism; Humans; Imipenem; Meropenem; Microbial Sensitivity Tests; Sulbactam; Thienamycins | 2014 |
A Non-inferiority Pilot Study Comparing the Clinical Efficacy and Safety of Generic Wide-spectrum Antibiotic Use in Septic Oncology Patients.
Topics: Administration, Intravenous; Anti-Bacterial Agents; Cefoperazone; Cilastatin; Cilastatin, Imipenem Drug Combination; Drug Combinations; Drugs, Generic; Female; Humans; Imipenem; Male; Middle Aged; Oncology Service, Hospital; Penicillanic Acid; Pilot Projects; Piperacillin; Piperacillin, Tazobactam Drug Combination; Prospective Studies; Retrospective Studies; Sepsis; Sulbactam; Treatment Outcome | 2015 |
[The activity of moxalactam against Enterobacteriaceae and anaerobia in vitro].
Topics: Anti-Bacterial Agents; Bacteria, Anaerobic; Cefoperazone; Enterobacteriaceae; Escherichia coli; Imipenem; Klebsiella pneumoniae; Meropenem; Microbial Sensitivity Tests; Moxalactam; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Proteus; Thienamycins | 2016 |
Trends in Drug Resistance of
Topics: Acinetobacter baumannii; Amikacin; Anti-Infective Agents; Cefepime; Cefoperazone; Ceftazidime; Cephalosporins; China; Colistin; Drug Resistance, Multiple, Bacterial; Humans; Imipenem; Levofloxacin; Microbial Sensitivity Tests; Minocycline; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Sulbactam | 2017 |
Antibiotics susceptibility patterns of uropathogenic E. coli with special reference to fluoroquinolones in different age and gender groups.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amikacin; Anti-Bacterial Agents; Cefoperazone; Child; Child, Preschool; Cross-Sectional Studies; Drug Resistance, Bacterial; Escherichia coli; Escherichia coli Infections; Female; Fluoroquinolones; Humans; Imipenem; Infant; Male; Meropenem; Microbial Sensitivity Tests; Middle Aged; Sulbactam; Tazobactam; Urinary Tract Infections; Young Adult | 2017 |
[Analysis of the distribution characteristics and drug resistance of non-fermenting bacterial infection in intensive care unit from 2009 to 2015]
Topics: Acinetobacter baumannii; Anti-Bacterial Agents; Bacterial Infections; Cefepime; Cefoperazone; Cephalosporins; Cross Infection; Drug Resistance; Drug Resistance, Bacterial; Gram-Negative Bacteria; Humans; Imipenem; Intensive Care Units; Meropenem; Microbial Sensitivity Tests; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Pseudomonas aeruginosa; Retrospective Studies; Thienamycins | 2016 |
AmpC beta-lactamases in Klebsiella pneumoniae: An emerging threat to the paediatric patients.
Topics: Adolescent; Amikacin; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Cefoperazone; Cefoxitin; Cephalosporins; Child; Child, Preschool; Ciprofloxacin; Cross-Sectional Studies; Disk Diffusion Antimicrobial Tests; Drug Combinations; Drug Resistance, Bacterial; Female; Hospitals, Pediatric; Humans; Imipenem; Infant; Infant, Newborn; Klebsiella Infections; Klebsiella pneumoniae; Levofloxacin; Male; Meropenem; Microbial Sensitivity Tests; Pakistan; Piperacillin, Tazobactam Drug Combination; Sulbactam | 2018 |
Determination of Total and Unbound Meropenem, Imipenem/Cilastatin, and Cefoperazone/Sulbactam in Human Plasma: Application for Therapeutic Drug Monitoring in Critically Ill Patients.
Topics: Cefoperazone; Chromatography, High Pressure Liquid; Cilastatin; Cilastatin, Imipenem Drug Combination; Critical Illness; Drug Monitoring; Humans; Imipenem; Meropenem; Plasma; Sulbactam; Tandem Mass Spectrometry | 2020 |